Bearclaw Capital Corp.

Bearclaw Capital Corp.

June 12, 2009 14:47 ET

Bearclaw Announces Grant of Options to Directors

VANCOUVER, BRITISH COLUMBIA--(Marketwire - June 12, 2009) - Bearclaw Capital Corp. (TSX VENTURE:BRL)(FRANKFURT:5BQ) announces that it has granted options to its three directors pursuant to its rolling 10% stock option plan. An option to acquire 300,000 common shares was granted to John B. Ross, who is also Bearclaw's President and Chief Executive Officer, and options to acquire 200,000 common shares were granted to each of Arthur Lilly and Robert MacGillivray. All of the options are for a five-year term which expires on June 5, 2014. For each grant, 30% vests immediately, 30% vests on the first anniversary of the grant and the remaining 40% vests on the second anniversary of the grant. The exercise price is $0.06 per common share.

This news release may contain forward-looking statements. Known and unknown risks and uncertainties may cause actual events or results to materially differ from those expressed or implied by any such forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the contents of this release.

Contact Information

  • Bearclaw Capital Corp.
    John B. Ross